A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
about
Valproate preparations for agitation in dementiaTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderEpilepsy and cognitive impairments in Alzheimer diseasePharmacology of epigenetics in brain disordersAlzheimer's therapies.Seizures and epilepsy in Alzheimer's diseaseSymptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.Valproate for treatment of agitation in neurosyphilis: a case report.Epigenetics-Based Therapeutics for Neurodegenerative Disorders.Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease.Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review.The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study.Management of behavioral problems in Alzheimer's disease.Use of psychostimulants in patients with dementia.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.Systemic and central immunity in Alzheimer's disease: therapeutic implications.Valproic acid in dementia: does an optimal dose exist?Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models.Use of atypical antipsychotics in the elderly.Anticonvulsants in the treatment of aggression in the demented elderly: an update.Alzheimer's Disease and Histone Code Alterations.Pharmacological treatments for alleviating agitation in dementia: A systematic review and network meta-analysis.Current Concepts of Neurodegenerative Mechanisms in Alzheimer's Disease.
P2860
Q24240034-B98550C4-F725-4410-9922-688B113A2B99Q24626017-C0ED4314-C305-4433-9D89-6F7DD4364C37Q33616746-79754B24-75F8-47DA-9F33-BDEDD20B215EQ33673025-074118D1-253B-4AE8-8A55-B144D8A01020Q33894697-AB7FF008-4CFD-4006-9ED7-5D2E80C2EA2DQ34070798-15BA81C9-CBE3-4C4F-A70C-7A651F9C6CFAQ35765716-D4C45047-B611-45E4-B72B-8142D53D0154Q36538414-06BF7FF9-09DE-4092-8075-9B4609B51DFDQ36697733-CC97A40E-26BC-402E-AAD9-27A8669C41C8Q36724965-D60C0D69-197A-420E-8F8C-B6BB1FDF99B7Q36948428-B68D6C9A-4FC9-45F2-9EDD-EB8F1898EE09Q37004363-6B9967B5-3873-457F-B28C-4E4196B1BB8BQ37019262-46DE0FA9-60CD-46CE-A66C-7D70D87BDB81Q37062566-C4EB7CC5-B6F9-465B-A421-7AD868C82AA8Q37680018-90293C66-2E83-403F-BE23-3245D92CAA75Q37782195-78DA2448-D3E3-4F64-8143-59168DA79F1EQ37834619-40630649-C804-4D04-ACAE-FE2F9D88045DQ37947984-C74C0B4E-7826-4A17-9E1C-4568BB43BC60Q37954456-5C3B1676-DFA4-4C01-8E5A-7146C6863B8DQ37957774-534BB57B-730E-4C7D-8835-1CA3ACB9D5FEQ38252709-18AE57BE-7B6E-4BB5-8CEA-9AF0FDEA80A0Q39924456-9DC59E3D-3397-4093-A385-392DEC60B258Q41507819-7C9C5538-20B4-4139-BAC5-DAF266ABF143Q42081136-A02CB3AD-B57C-4772-B500-1318084FD7A3Q50993017-BA49311A-7008-4876-8134-0D9F4A86448FQ53279360-7CDF4CFA-8007-4107-98C6-B929167F18B8Q54942608-494ED3B3-FBB5-46C6-8E11-D5CF6483C576
P2860
A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A placebo-controlled trial of ...... ession in Alzheimer's disease.
@en
A placebo-controlled trial of ...... ession in Alzheimer's disease.
@nl
type
label
A placebo-controlled trial of ...... ession in Alzheimer's disease.
@en
A placebo-controlled trial of ...... ession in Alzheimer's disease.
@nl
prefLabel
A placebo-controlled trial of ...... ession in Alzheimer's disease.
@en
A placebo-controlled trial of ...... ession in Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
A placebo-controlled trial of ...... ession in Alzheimer's disease.
@en
P2093
Goran Eryavec
Lana S Rothenburg
Nathan Herrmann
P2860
P304
P356
10.1159/000097757
P577
2006-12-04T00:00:00Z